LENSAR, INC. Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- LENSAR, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2026-06-30 was $259.00K, a 48.00% increase year-over-year.
- LENSAR, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-06-30 was $175.00K, a 2.94% increase year-over-year.
- LENSAR, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2024-06-30 was $170.00K, a 6.08% decline year-over-year.
- LENSAR, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2023-06-30 was $181.00K, a 14.62% decline year-over-year.
- LENSAR, INC. stock issued during period, value, employee stock purchase plan for fiscal 2025 was $590.00K, a 92.81% increase from fiscal 2024.
- LENSAR, INC. stock issued during period, value, employee stock purchase plan for fiscal 2024 was $306.00K, a 6.42% decline from fiscal 2023.
- LENSAR, INC. stock issued during period, value, employee stock purchase plan for fiscal 2023 was $327.00K, a 19.85% decline from fiscal 2022.
- LENSAR, INC. stock issued during period, value, employee stock purchase plan for fiscal 2022 was $408.00K, a 13.02% increase from fiscal 2021.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2026-06-30 | $259.00K 10-Q · filed 2026-08-13 | |
| 2025-12-31 | $590.00K 10-K · filed 2026-03-31 | |
| 2025-06-30 | $175.00K 10-Q · filed 2026-08-13 | |
| 2024-12-31 | $306.00K 10-K · filed 2026-03-31 | |
| 2024-06-30 | $170.00K 10-Q · filed 2025-11-06 | |
| 2023-12-31 | $327.00K 10-K · filed 2025-02-27 | |
| 2023-06-30 | $181.00K 10-Q · filed 2024-11-07 | |
| 2022-12-31 | $408.00K 10-K · filed 2024-03-04 | |
| 2022-06-30 | $212.00K 10-Q · filed 2023-11-09 | |
| 2021-12-31 | $361.00K 10-K · filed 2023-03-16 | |
| 2021-06-30 | $170.00K 10-Q · filed 2022-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B |